HLA-DRB1: A new potential prognostic factor and therapeutic target of cutaneous melanoma and an indicator of tumor microenvironment remodeling
Cutaneous melanoma (CM) is the most common skin cancer and one of the most aggressive cancers and its incidence has risen dramatically over the past few decades. The tumor microenvironment (TME) plays a crucial role in the occurrence and development of cutaneous melanoma. Nevertheless, the dynamics...
Main Authors: | Huiling Deng, Yuxuan Chen, Jiecong Wang, Ran An |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491554/?tool=EBI |
Similar Items
-
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
by: Dadras, S, et al.
Published: (2003) -
No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.
by: Handel, A, et al.
Published: (2010) -
Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso
by: Alfred Rakissida Ouedraogo, et al.
Published: (2023-10-01) -
Hematological parameters in patients with rheumatoid arthritis and gene variants HLA-DRB1*04 and HLA-DRB1*03
by: Biljana Klimenta, et al.
Published: (2020-06-01) -
The Keratinocyte in the Picture Cutaneous Melanoma Microenvironment
by: Ramona Marrapodi, et al.
Published: (2024-02-01)